Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) EBITDA
Chemed Corporation's EBITDA for fiscal 2025 was $403.4M, down 6.15% from $429.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was $438.8M. Over the past ten years it has ranged from $150.4M (fiscal 2017) to $446.6M (fiscal 2020); the current reading is higher than 82% of that period. Chemed Corporation ranks 14th of 48 Medical Care Facilities companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $403.4M | (6.15%) |
| FY2024 | $429.9M | 6.93% |
| FY2023 | $402.0M | (0.25%) |
| FY2022 | $403.0M | 0.15% |
| FY2021 | $402.4M | (9.89%) |
| FY2020 | $446.6M | 47.44% |
| FY2019 | $302.9M | 6.88% |
| FY2018 | $283.4M | 88.41% |
| FY2017 | $150.4M | (30.29%) |
| FY2016 | $215.8M | (2.19%) |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $113.9M | 7.19% |
| Jun 2026 | $106.3M | 4.67% |
| Mar 2026 | $101.5M | (13.27%) |
| Dec 2025 | $117.1M | 28.55% |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | $3.8B |
| DVA DaVita Inc. compare | $2.8B |
| UHS Universal Health Services, Inc. compare | $2.7B |
| ENSG The Ensign Group, Inc. compare | $630.9M |
| PACS PACS Group, Inc. compare | $500.6M |
| CON Concentra Group Holdings Parent, Inc. compare | $479.6M |
| CHE Chemed Corporation | $438.8M |
| OPCH Option Care Health, Inc. compare | $408.3M |
| LFST LifeStance Health Group, Inc. compare | $161.1M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CHE
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement